FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384126415> ?p ?o ?g. }

• W4384126415 endingPage "923" @default.
• W4384126415 startingPage "915" @default.
• W4384126415 abstract "To investigate the effect of acetylcorynoline (Ace) for promoting functional recovery of injured spinal cord in rats and explore the underlying mechanism.Rat models of spinal cord injury (SCI) were treated with intraperitoneal injection of different concentrations of Ace, with the sham-operated rats as the control group. After the treatment, the changes in motor function of the rats and the area of spinal cord injury were assessed with BBB score and HE staining, and the changes in pro-inflammatory cytokine levels and microglial activation were determined using PCR, ELISA and immunofluorescence staining. In a lipopolysaccharide (LPS)-treated BV2 cell model, the effects of different concentrations of Ace or DMSO on microglial activation and inflammatory cytokine production were observed. Network pharmacology analysis was performed to predict the target protein and signaling mechanism that mediated the inhibitory effect of Ace on microglia activation, and AutoDock software was used for molecular docking between Ace and the target protein. A signaling pathway blocker (Osimertinib) was used to verify the signaling mechanism in rat models of SCI and LPS-treated BV2 cell model.In rat models of SCI, Ace treatment significantly increased the BBB score, reduced the area of spinal cord injury, and lowered the number of activated microglia cells and the levels of pro-inflammatory cytokines (P < 0.05). The cell experiments showed that Ace treatment significantly lower the level of cell activation and the production of inflammatory cytokines in LPS-treated BV2 cells (P < 0.05). Network pharmacology analysis suggested that EGFR was the main target of Ace, and they bound to each other via hydrogen bonds as shown by molecular docking. Western blotting confirmed that Ace inhibited the activation of the EGFR/MAPK signaling pathway in injured mouse spinal cord tissue and in LPS-treated BV2 cells, and its inhibitory effect was comparable to that of Osimertinib.In rat models of SCI, treatment with Ace can inhibit microglia-mediated inflammatory response by regulating the EGFR/MAPK pathway, thus promoting tissue repair and motor function recovery." @default.
• W4384126415 created "2023-07-14" @default.
• W4384126415 creator A5016688487 @default.
• W4384126415 creator A5020223373 @default.
• W4384126415 creator A5037537662 @default.
• W4384126415 creator A5052883326 @default.
• W4384126415 creator A5054856936 @default.
• W4384126415 creator A5058379492 @default.
• W4384126415 creator A5079691548 @default.
• W4384126415 creator A5084578229 @default.
• W4384126415 date "2023-06-20" @default.
• W4384126415 modified "2023-10-09" @default.
• W4384126415 title "[Acetylcorynoline inhibits microglia activation by regulating EGFR/MAPK signaling to promote functional recovery of injured mouse spinal cord]." @default.
• W4384126415 cites W2062652295 @default.
• W4384126415 cites W2073427034 @default.
• W4384126415 cites W2102421004 @default.
• W4384126415 cites W2170147460 @default.
• W4384126415 cites W2527645962 @default.
• W4384126415 cites W2611783245 @default.
• W4384126415 cites W2753264072 @default.
• W4384126415 cites W2770429776 @default.
• W4384126415 cites W2799421001 @default.
• W4384126415 cites W2799458925 @default.
• W4384126415 cites W2807183210 @default.
• W4384126415 cites W2899720930 @default.
• W4384126415 cites W2912001558 @default.
• W4384126415 cites W2941075737 @default.
• W4384126415 cites W2946906538 @default.
• W4384126415 cites W2966090991 @default.
• W4384126415 cites W2988734671 @default.
• W4384126415 cites W2990111539 @default.
• W4384126415 cites W3067269879 @default.
• W4384126415 cites W3103806518 @default.
• W4384126415 cites W3136922620 @default.
• W4384126415 cites W3138044072 @default.
• W4384126415 cites W3201232760 @default.
• W4384126415 cites W3211219536 @default.
• W4384126415 cites W4205152591 @default.
• W4384126415 cites W4211101637 @default.
• W4384126415 cites W4223467650 @default.
• W4384126415 cites W4225313172 @default.
• W4384126415 cites W4225935984 @default.
• W4384126415 cites W4306879915 @default.
• W4384126415 doi "https://doi.org/10.12122/j.issn.1673-4254.2023.06.06" @default.
• W4384126415 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37439163" @default.
• W4384126415 hasPublicationYear "2023" @default.
• W4384126415 type Work @default.
• W4384126415 citedByCount "0" @default.
• W4384126415 crossrefType "journal-article" @default.
• W4384126415 hasAuthorship W4384126415A5016688487 @default.
• W4384126415 hasAuthorship W4384126415A5020223373 @default.
• W4384126415 hasAuthorship W4384126415A5037537662 @default.
• W4384126415 hasAuthorship W4384126415A5052883326 @default.
• W4384126415 hasAuthorship W4384126415A5054856936 @default.
• W4384126415 hasAuthorship W4384126415A5058379492 @default.
• W4384126415 hasAuthorship W4384126415A5079691548 @default.
• W4384126415 hasAuthorship W4384126415A5084578229 @default.
• W4384126415 hasConcept C118552586 @default.
• W4384126415 hasConcept C126322002 @default.
• W4384126415 hasConcept C164027704 @default.
• W4384126415 hasConcept C185592680 @default.
• W4384126415 hasConcept C25498285 @default.
• W4384126415 hasConcept C2776914184 @default.
• W4384126415 hasConcept C2778334475 @default.
• W4384126415 hasConcept C2778690821 @default.
• W4384126415 hasConcept C2779830541 @default.
• W4384126415 hasConcept C2780159080 @default.
• W4384126415 hasConcept C2780775167 @default.
• W4384126415 hasConcept C55493867 @default.
• W4384126415 hasConcept C57074206 @default.
• W4384126415 hasConcept C62478195 @default.
• W4384126415 hasConcept C71924100 @default.
• W4384126415 hasConcept C87753298 @default.
• W4384126415 hasConcept C98274493 @default.
• W4384126415 hasConceptScore W4384126415C118552586 @default.
• W4384126415 hasConceptScore W4384126415C126322002 @default.
• W4384126415 hasConceptScore W4384126415C164027704 @default.
• W4384126415 hasConceptScore W4384126415C185592680 @default.
• W4384126415 hasConceptScore W4384126415C25498285 @default.
• W4384126415 hasConceptScore W4384126415C2776914184 @default.
• W4384126415 hasConceptScore W4384126415C2778334475 @default.
• W4384126415 hasConceptScore W4384126415C2778690821 @default.
• W4384126415 hasConceptScore W4384126415C2779830541 @default.
• W4384126415 hasConceptScore W4384126415C2780159080 @default.
• W4384126415 hasConceptScore W4384126415C2780775167 @default.
• W4384126415 hasConceptScore W4384126415C55493867 @default.
• W4384126415 hasConceptScore W4384126415C57074206 @default.
• W4384126415 hasConceptScore W4384126415C62478195 @default.
• W4384126415 hasConceptScore W4384126415C71924100 @default.
• W4384126415 hasConceptScore W4384126415C87753298 @default.
• W4384126415 hasConceptScore W4384126415C98274493 @default.
• W4384126415 hasIssue "6" @default.
• W4384126415 hasLocation W43841264151 @default.
• W4384126415 hasOpenAccess W4384126415 @default.
• W4384126415 hasPrimaryLocation W43841264151 @default.
• W4384126415 hasRelatedWork W2005022924 @default.
• W4384126415 hasRelatedWork W2048108724 @default.
• W4384126415 hasRelatedWork W2069473589 @default.

• next